| Unique ID issued by UMIN | UMIN000063596 |
|---|---|
| Receipt number | R000072780 |
| Scientific Title | Effects of Exercise and Training under Hypoxic Conditions on the Human Body |
| Date of disclosure of the study information | 2026/11/11 |
| Last modified on | 2026/11/11 18:04:30 |
Effects of breathing low-oxygen air during recovery periods on exercise power and physiological responses during repeated high-intensity cycling
IEH Cycling Study
Effects of Exercise and Training under Hypoxic Conditions on the Human Body
IEH Cycling Study
| Japan |
Healthy adults
| Adult |
Others
NO
This study aims to investigate the effects of inter-effort hypoxic exposure (IEH) on mean power output and acute physiological responses during repeated-sprint cycling exercise in healthy adult males who engage in regular physical exercise. A randomized crossover design will be used, in which each participant completes three experimental conditions: normoxia (NOR), continuous hypoxia (HYP), and inter-effort hypoxic exposure (IEH). The primary outcome will be mean power output across 16 sprints, with the comparison between IEH and HYP designated as the primary contrast. Secondary outcomes will include peripheral oxygen saturation, peak power output, blood lactate concentration, and rating of perceived exertion.
Efficacy
Exploratory
Explanatory
Not applicable
Mean power output (MPO, W) during repeated-sprint cycling exercise. Under each experimental condition, participants will perform four sets of four 10-s all-out cycling sprints (16 sprints in total) against a resistance equivalent to 7.5% of body mass. MPO will be calculated for each 10-s sprint, and the arithmetic mean of all 16 sprint values will be used as the representative MPO for each condition. MPO will be assessed under normoxic (NOR), continuous hypoxic (HYP), and inter-effort hypoxic exposure (IEH) conditions, with IEH versus HYP designated as the primary contrast.
1. Peripheral oxygen saturation (SpO2, %): Measured before warm-up and at 0, 30, 60, 90, 120, 150, 180, 210, and 240 s after each set. Mean observed SpO2, minimum observed SpO2, and time-dependent changes during each recovery period will be evaluated.
2. Peak power output (PPO, W): Measured during each 10-s sprint and compared across experimental conditions and sets.
3. Blood lactate concentration (mmol/L): Measured using fingertip capillary blood samples collected before warm-up and 120 s after each set.
4. Rating of perceived exertion (RPE): Assessed immediately after each set using the modified Borg CR10 scale.
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is not considered as adjustment factor.
YES
Numbered container method
6
Educational,Counseling,Training
| Behavior,custom |
Participants will complete three repeated-sprint cycling trials in the following order: NOR, HYP, and IEH, with at least 72 h between trials.
In each trial, participants will perform four sets of four 10-s all-out cycling sprints (16 sprints in total) at a resistance equivalent to 7.5% of body mass. Passive recovery will be 20 s between sprints and 5 min between sets.
In the NOR condition, participants will breathe ambient room air throughout exercise and recovery. In the HYP condition, participants will breathe hypoxic gas (FiO2 = 13.5%) continuously from the start of the first set until the end of the 5-min recovery after the fourth set.
In the IEH condition, all sprints and 20-s intra-set recovery periods will be performed under normoxia. During the 5-min recovery periods after sets 1-3, participants will breathe hypoxic gas (FiO2 = 13.5%) for the first 4 min 30 s, followed by normoxia for the final 30 s. After the fourth set, hypoxic exposure will continue throughout the entire 5-min recovery period.
Participants will complete the three repeated-sprint cycling conditions in the following order: NOR, IEH, HYP. The exercise protocol and oxygen exposure conditions will be identical to those described in Intervention 1, with at least 72 h between trials.
Participants will complete the three repeated-sprint cycling conditions in the following order: HYP, NOR, IEH. The exercise protocol and oxygen exposure conditions will be identical to those described in Intervention 1, with at least 72 h between trials.
Participants will complete the three repeated-sprint cycling conditions in the following order: HYP, IEH, NOR. The exercise protocol and oxygen exposure conditions will be identical to those described in Intervention 1, with at least 72 h between trials.
Participants will complete the three repeated-sprint cycling conditions in the following order: IEH, NOR, HYP. The exercise protocol and oxygen exposure conditions will be identical to those described in Intervention 1, with at least 72 h between trials.
Participants will complete the three repeated-sprint cycling conditions in the following order: IEH, HYP, NOR. The exercise protocol and oxygen exposure conditions will be identical to those described in Intervention 1, with at least 72 h between trials.
| 18 | years-old | <= |
| Not applicable |
Male
1. Healthy males aged 18 years or older.
2. Individuals who regularly engage in physical exercise at least twice per week for at least 30 minutes per session.
3. Individuals who are considered suitable for high-intensity cycling exercise and hypoxic exposure based on a health questionnaire and interview.
4. Individuals who have received sufficient information about the study objectives, procedures, and potential risks and have provided written informed consent.
5. Individuals who are able to participate in all experimental conditions specified in the study protocol.
1. Individuals with cardiovascular, respiratory, metabolic, or other medical conditions that may interfere with or contraindicate high-intensity exercise or hypoxic exposure.
2. Individuals with a history of chest pain, severe dyspnea, dizziness, syncope, or other concerning symptoms during high-intensity exercise.
3. Individuals with musculoskeletal disorders that prevent safe performance of high-intensity cycling exercise.
4. Individuals taking medications that may affect exercise performance, cardiovascular or respiratory responses, or oxygen saturation, when such medications are considered to compromise participant safety or study outcomes.
5. Individuals considered unsuitable for hypoxic exposure or high-intensity exercise based on a health questionnaire, interview, or resting oxygen saturation.
6. Individuals otherwise deemed unsuitable for participation by the principal investigator for safety-related or study-related reasons.
18
| 1st name | Toshihiro |
| Middle name | |
| Last name | Yasuda |
Fukushima University
Faculty of Human Development and Culture
960-1296
1 Kanayagawa, Fukushima 960-1296, Japan
024-548-8209
yasuda@educ.fukushima-u.ac.jp
| 1st name | Toshihiro |
| Middle name | |
| Last name | Yasuda |
Fukushima University
Faculty of Human Development and Culture
960-1296
1 Kanayagawa, Fukushima, Japan
024-548-8209
yasuda@educ.fukushima-u.ac.jp
Fukushima University
Fukushima University
Self funding
Japan
Japan Society for the Promotion of Science (JSPS KAKENHI, Grant Number 25K14687)
Fukushima University Research Ethics Committee
1 Kanayagawa, Fukushima, Japan
024-548-5298
kyoudo@adb.fukushima-u.ac.jp
NO
福島大学 保健体育棟107号室 生理学実験室(福島県)
| 2026 | Year | 11 | Month | 11 | Day |
Unpublished
Yes (conditional sharing upon reasonable request)
De-identified individual participant data will not be made publicly available in an open repository. Data may be shared by the principal investigator upon reasonable request, subject to evaluation of the research purpose, ethical appropriateness, and protection of participant confidentiality.
Preinitiation
| 2026 | Year | 11 | Month | 11 | Day |
| 2025 | Year | 03 | Month | 27 | Day |
| 2026 | Year | 11 | Month | 16 | Day |
| 2026 | Year | 12 | Month | 31 | Day |
This study is an independent intervention trial conducted under the broader research protocol entitled "Effects of Exercise and Training under Hypoxic Conditions on the Human Body," approved by the Fukushima University Research Ethics Committee (approval number 2024-40; March 27, 2025). This trial is distinct from the previous VHL-RST study conducted under the same ethics approval and will be prospectively registered in UMIN-CTR before enrollment of the first participant.
| 2026 | Year | 11 | Month | 11 | Day |
| 2026 | Year | 11 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072780